Anlauf, M.; Neumann, M.; Bomberg, S. et al.
Neuroendocrine neoplasms of the breastPATHOLOGE. Bd. 36. H. 3. 2015 S. 261-270
Darstein, F.; Koenig, C.; Hoppe-Lotichius, M. et al.
New onset of diabetes after transplantation is associated with improved patient survival after liver transplantation due to confounding factorEUROPEAN JOURNAL OF INTERNAL MEDICINE. Bd. 26. H. 6. 2015 S. 439-444
Schattenberg, Joern M.
Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional AspectsERNAHRUNGS UMSCHAU. Bd. 62. H. 2. 2015 S. M92-M100
Wagner, Anna Dorothea; Moehler, Markus; Grothe, Wilfried et al.
Novel chemotherapy combinations for metastatic gastric adenocarcinoma (mAGC): An updated meta-analysisJOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 3. 2015
Nguyen-Tat, M.; Schattenberg, J. M.
Overt hepatic encephalopathy: extension of therapeutic armamentarium by old friends?ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 53. H. 7. 2015 S. 724-725
Vogel, Arndt; Kasper, Stefan; Weichert, Wilko et al.
Panitumumab in combination with gemcitabine/cisplatin (GemCis) for patients with advanced kRAS WT biliary tract cancer: A randomized phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 15. 2015
Stahl, Michael; Mihaljevic, Andre L.; Moehler, Markus et al.
Perioperative chemotherapy with ECX plus /- panitumumab in locally advanced gastroesophageal adenocarcinomas (GEA): A randomized study of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the German Cancer Society.JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 3. 2015
Wolin, Edward M.; Jarzab, Barbara; Eriksson, Barbro et al.
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analoguesDRUG DESIGN DEVELOPMENT AND THERAPY. Bd. 9. 2015 S. 5075-5086
Nielsen, Mette J.; Veidal, Sanne S.; Karsdal, Morten A. et al.
Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis CLIVER INTERNATIONAL. Bd. 35. H. 2. 2015 S. 429-437
Knop, V.; Herrmann, E.; Vermehren, J. et al.
PREDICTION OF HBsAg SEROCLEARANCE AND HBsAg SEROCONVERSION IN A COHORT OF INACTIVE EUROPEAN HEPATITIS B (HBV) CARRIERS: A PROSPECTIVE LONGITUDINAL STUDY (ALBATROS STUDY)JOURNAL OF HEPATOLOGY. Bd. 62. 2015 S. S533-S534